Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-14

Clinical Trial Update: Clinical and Refractive Outcomes After Contoura® Refractive Surgery Planned Using Phorcides Surgery Planning Software

View source ↗

Summary

Study evaluating clinical and refractive outcomes after Contoura refractive surgery planned with Phorcides planning software completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Contoura refractive surgery

Snippet

Sponsor: American Corneal Consultants | Conditions: Refractive Errors | Status: COMPLETED | Results posted: 2022-04-14